KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Change in Acquisitions & Divestments (2016 - 2026)

Gilead Sciences filings provide 17 years of Change in Acquisitions & Divestments readings, the most recent being $822.0 million for Q4 2025.

  • On a quarterly basis, Change in Acquisitions & Divestments fell 57.59% to $822.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $854.0 million, a 62.3% decrease, with the full-year FY2025 number at $854.0 million, down 62.3% from a year prior.
  • Change in Acquisitions & Divestments hit $822.0 million in Q4 2025 for Gilead Sciences, up from $17.0 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $2.3 billion in Q1 2024 to a low of -$1.9 billion in Q2 2024.
  • Median Change in Acquisitions & Divestments over the past 5 years was $211.0 million (2023), compared with a mean of $265.1 million.
  • The widest YoY moves for Change in Acquisitions & Divestments: up 1877.55% in 2024, down 590.63% in 2024.
  • Gilead Sciences' Change in Acquisitions & Divestments stood at -$1.1 billion in 2021, then soared by 103.9% to $42.0 million in 2022, then surged by 133.33% to $98.0 million in 2023, then soared by 1877.55% to $1.9 billion in 2024, then tumbled by 57.59% to $822.0 million in 2025.
  • The last three reported values for Change in Acquisitions & Divestments were $822.0 million (Q4 2025), $17.0 million (Q3 2025), and $15.0 million (Q2 2025) per Business Quant data.